Federated Hermes’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-123
Closed -$3.81K 2211
2025
Q1
$3.81K Sell
123
-239
-66% -$7.96K ﹤0.01% 1907
2024
Q4
$11.4K Buy
362
+64
+21% +$3.04K ﹤0.01% 1828
2024
Q3
$17.3K Buy
298
+118
+66% +$5.8K ﹤0.01% 1761
2024
Q2
$7.3K Hold
180
﹤0.01% 1807
2024
Q1
$7.56K Buy
180
+1
+0.6% +$39 ﹤0.01% 1804
2023
Q4
$6.86K Sell
179
-17
-9% -$566 ﹤0.01% 1824
2023
Q3
$6.05K Buy
196
+3
+2% +$104 ﹤0.01% 1866
2023
Q2
$6.1K Buy
+193
New +$6.62K ﹤0.01% 1887
2021
Q4
Sell
-630
Closed -$57K 2327
2021
Q3
$57K Sell
630
-12,930
-95% -$1.1M ﹤0.01% 1852
2021
Q2
$852K Buy
13,560
+13,521
+34,669% +$500K ﹤0.01% 1366
2021
Q1
$1K Buy
+39
New +$938 ﹤0.01% 2197

Other funds holding ASTH

Federated Hermes's ASTH Position: Q2 2025 in Review

Federated Hermes sold out of Astrana Health (ASTH) in Q2 2025, closing a stake of 123 shares — an estimated $3.81K sold.

Federated Hermes first reported a position in ASTH in Q1 2021 and held it in 11 quarters. The position peaked at $852K in Q2 2021. 162 funds tracked by Wall St. Rank hold ASTH as of Q2 2025.

  • Federated Hermes reported no remaining Astrana Health position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 123 Astrana Health shares in Q2 2025, an estimated $3.81K.
  • Federated Hermes first reported a position in Astrana Health in Q1 2021 and held it in 11 quarters.
  • Federated Hermes's Astrana Health position peaked at $852K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Astrana Health as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.